A Study to Assess APO866 for the Treatment of Advanced Melanoma

NCT00432107 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
25
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Valerio Therapeutics